Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Merck |
---|---|
Information provided by: | Merck |
ClinicalTrials.gov Identifier: | NCT00397683 |
The purpose of this study is to test MK0822 on disease activity in patients with osteoarthritis in the knee. Disease modifying activity of MK0822 will be assessed by measurements of knee cartilage using Magnetic Resonance Imaging (MRI) of the knee.
This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).
Condition | Intervention | Phase |
---|---|---|
Osteoarthritis |
Drug: MK0822 |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Proprietary Information - Exploratory (Non-Confirmatory) Trial |
Ages Eligible for Study: | 40 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, California | |
Call for Information | |
Pomona, California, United States, 91767 | |
Call for Information | |
Torrance, California, United States, 90505 | |
Call for Information | |
Palm Desert, California, United States, 92260 | |
Call for Information | |
Upland, California, United States, 91786 | |
United States, Florida | |
Call for Information | |
Hialeah, Florida, United States, 33010 | |
Call for Information | |
South Miami, Florida, United States, 33143-0000 | |
Call for Information | |
Coral Gables, Florida, United States, 33134 | |
United States, New York | |
Call for Information | |
Rochester, New York, United States, 14618 | |
Call for Information | |
Rochester, New York, United States, 14168 | |
Call for Information | |
Rochester, New York, United States, 14609 | |
United States, Pennsylvania | |
Call for Information | |
Norristown, Pennsylvania, United States, 19401 | |
Call for Information | |
Perkasie, Pennsylvania, United States, 18944 | |
Chile | |
Merck Sharp & Dohme (I.A.) Corp. | |
Santiago, Chile, 6761641 | |
Colombia, Cundinamarca | |
Frosst Laboratories Inc. | |
Bogota, Cundinamarca, Colombia | |
Mexico, D.F. | |
Merck Sharp & Dohme De Mexico, S.A. De C.V. | |
Mexico, D.F., Mexico, 1090 | |
Poland | |
MSD Polska Sp. z o.o. Dzial Medyczny | |
Warszawa, Poland, 00-867 |
Study Director: | Medical Monitor | Merck |
Study ID Numbers: | 2006_517 |
Study First Received: | November 8, 2006 |
Last Updated: | April 6, 2007 |
ClinicalTrials.gov Identifier: | NCT00397683 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Osteoarthritis, Knee Musculoskeletal Diseases Osteoarthritis |
Joint Diseases Arthritis Rheumatic Diseases |
Osteoarthritis, Knee Musculoskeletal Diseases Osteoarthritis |
Joint Diseases Arthritis Rheumatic Diseases |